Antimicrobial and Cytotoxic Activities of Neolignans from Magnolia officinalis
Authors:
- 25 March 2004
- journal article
- research article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 1 (3) , 530-537
Abstract
In the light of the steady increase of infections related to vancomycin‐resistant enterococci (VRE) and methicillin‐resistant Staphylococcus aureus (MRSA), the medicinal plant Magnolia officinalis was subjected to bioassay‐directed fractionation, which led to the isolation of the known neolignans piperitylmagnolol (1), magnolol (2), and honokiol (3) from the MeOH extract. In broth‐microdilution assays, 1–3 exhibited antibacterial activities against VRE and MRSA at minimum‐inhibitory concentrations (MIC) in the range of 6.25–25 μg/ml, compound 1 being the most‐potent antibiotic. The ratio of MBC/MIC (MBC=minimum bactericidal concentration) was ≤2 for all compounds. The kinetics of the antibacterial action of 1 and 3 were studied by means of time‐kill assays; both compounds were bactericidal against VRE and MRSA, their actions being time dependent, or both time and concentration dependent. Magnolol (2) was acetylated to magnolol monoacetate (4) and magnolol diacetate (5) (partial or full masking of the phenolic OH functions). The cytotoxic properties of 1–5 against human OVCAR‐3 (ovarian adenocarcinoma), HepG2 (hepatocellular carcinoma), and HeLa (cervical epitheloid carcinoma) cell lines were evaluated. The CD50 values for compounds 1–3 were in the range of 3.3–13.3 μg/ml, derivatives 4 and 5 being much less potent. This study indicates that piperitylmagnolol (=3‐[(1S,6S)‐6‐isopropyl‐3‐methylcyclohex‐2‐enyl]‐5,5′‐di(prop‐2‐enyl)[1,1′‐biphenyl]‐2,2′‐diol; 1) possesses both significant anti‐VRE activity and moderate cytotoxicity against the above cancer cell lines.Keywords
This publication has 33 references indexed in Scilit:
- Cytotoxic and Novel Compounds from Solanum indicumJournal of Natural Products, 2001
- Extraction, Assay, and Analysis of Antimicrobials from Plants with Activity Against Dental Pathogens ( Streptococcus sp.)The Journal of Alternative and Complementary Medicine, 1998
- Synthesis of (-)-Monoterpenylmagnolol and MagnololThe Journal of Organic Chemistry, 1995
- Studies on Inhibitors of Skin Tumor Promotion, IX. Neolignans from Magnolia officinalisJournal of Natural Products, 1991
- Bioactive neolignans from the leaves of Magnolia virginianaPhytochemistry, 1991
- Methicillin-Resistant Staphylococcus aureusNew England Journal of Medicine, 1989
- Randainol: a neolignan from sassafras randaiensePhytochemistry, 1984
- Biphenyls from the heartwood of taiwan sassafrasPhytochemistry, 1983
- Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb.Chemical and Pharmaceutical Bulletin, 1982
- Antimicrobial Activity of Phenolic Constituents of Magnolia Grandiflora L.Journal of Pharmaceutical Sciences, 1981